Sarah S. Donaldson

34.4k total citations · 9 hit papers
350 papers, 23.3k citations indexed

About

Sarah S. Donaldson is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Sarah S. Donaldson has authored 350 papers receiving a total of 23.3k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Pulmonary and Respiratory Medicine, 108 papers in Pathology and Forensic Medicine and 88 papers in Surgery. Recurrent topics in Sarah S. Donaldson's work include Sarcoma Diagnosis and Treatment (115 papers), Lymphoma Diagnosis and Treatment (68 papers) and Childhood Cancer Survivors' Quality of Life (65 papers). Sarah S. Donaldson is often cited by papers focused on Sarcoma Diagnosis and Treatment (115 papers), Lymphoma Diagnosis and Treatment (68 papers) and Childhood Cancer Survivors' Quality of Life (65 papers). Sarah S. Donaldson collaborates with scholars based in United States, Canada and United Kingdom. Sarah S. Donaldson's co-authors include Leslie L. Robison, Ann Mertens, Michael P. Link, Marilyn Stovall, Joseph P. Neglia, Wendy M. Leisenring, Charles A. Sklar, Marilyn Stovall, Anna T. Meadows and James R. Anderson and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Sarah S. Donaldson

343 papers receiving 22.4k citations

Hit Papers

Addition of Ifosfamide and Etoposide to Standard Chemothe... 1995 2026 2005 2015 2003 2009 2001 1995 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone
    2003 948 citations Holcombe E. Grier, Mark Krailo et al. profile →
  2. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
    2009 804 citations Toana Kawashima, Marilyn Stovall et al. profile →
  3. Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
    2001 737 citations William M. Crist, James R. Anderson et al. Journal of Clinical Oncology profile →
  4. The Third Intergroup Rhabdomyosarcoma Study.
    1995 732 citations E. A. Gehan, Sarah S. Donaldson et al. Journal of Clinical Oncology profile →
  5. Study design and cohort characteristics of the childhood cancer survivor study: A multi‐institutional collaborative project
    2002 553 citations Leslie L. Robison, Ann Mertens et al. profile →
  6. Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study
    2001 546 citations Joseph P. Neglia, Debra L. Friedman et al. profile →
  7. The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research
    2009 506 citations Leslie L. Robison, Gregory T. Armstrong et al. Journal of Clinical Oncology profile →
  8. Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
    2010 468 citations Debra L. Friedman, John Whitton et al. profile →
  9. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
    2013 319 citations Daniel M. Green, John Whitton et al. Pediatric Blood & Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah S. Donaldson United States 80 9.5k 6.4k 5.7k 5.2k 5.0k 350 23.3k
Helmut Gadner Austria 73 4.8k 0.5× 3.0k 0.5× 3.3k 0.6× 5.2k 1.0× 3.9k 0.8× 408 20.4k
Mark Krailo United States 76 6.8k 0.7× 1.9k 0.3× 2.7k 0.5× 2.0k 0.4× 5.7k 1.1× 392 18.7k
Anna T. Meadows United States 82 4.0k 0.4× 10.4k 1.6× 2.5k 0.4× 7.2k 1.4× 4.2k 0.8× 229 22.0k
Holcombe E. Grier United States 57 5.7k 0.6× 3.0k 0.5× 1.8k 0.3× 2.5k 0.5× 2.4k 0.5× 145 11.7k
Andrea Ferrari Italy 61 7.2k 0.8× 2.2k 0.3× 3.2k 0.6× 1.3k 0.3× 4.7k 0.9× 486 14.3k
Larry E. Kun United States 77 6.0k 0.6× 4.0k 0.6× 2.3k 0.4× 3.1k 0.6× 2.4k 0.5× 373 20.5k
Nancy J. Tarbell United States 73 5.7k 0.6× 2.0k 0.3× 2.2k 0.4× 2.0k 0.4× 1.9k 0.4× 219 14.3k
Marilyn Stovall United States 74 3.5k 0.4× 5.8k 0.9× 2.1k 0.4× 4.7k 0.9× 3.7k 0.7× 166 16.9k
James R. Anderson United States 66 7.3k 0.8× 1.3k 0.2× 4.5k 0.8× 1.1k 0.2× 4.3k 0.9× 232 14.4k
Robert E. Scully United States 92 6.2k 0.7× 1.1k 0.2× 3.1k 0.5× 3.2k 0.6× 3.7k 0.7× 1.5k 32.3k

Countries citing papers authored by Sarah S. Donaldson

Since Specialization
Citations

This map shows the geographic impact of Sarah S. Donaldson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah S. Donaldson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah S. Donaldson more than expected).

Fields of papers citing papers by Sarah S. Donaldson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah S. Donaldson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah S. Donaldson. The network helps show where Sarah S. Donaldson may publish in the future.

Co-authorship network of co-authors of Sarah S. Donaldson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah S. Donaldson. A scholar is included among the top collaborators of Sarah S. Donaldson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah S. Donaldson. Sarah S. Donaldson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Totadri, Sidharth, Deepak Bansal, Sarah S. Donaldson, et al.. (2023). Common queries in managing rhabdomyosarcoma in low‐ and middle‐income countries: An Indo‐North American collaboration. Pediatric Blood & Cancer. 70(11). e30616–e30616.
2.
Allen‐Rhoades, Wendy, Leo Mascarenhas, Wei Xue, et al.. (2022). ARST2031: A study to compare early use of vinorelbine and maintenance therapy for patients with high risk rhabdomyosarcoma.. Journal of Clinical Oncology. 40(16_suppl). TPS11591–TPS11591. 5 indexed citations
3.
Donaldson, Sarah S., et al.. (2022). Adherence to topical glaucoma therapy in patients attending virtual clinics. Eye. 37(9). 1922–1927. 1 indexed citations
4.
Yechieli, Raphael, Henry Mandeville, Susan M. Hiniker, et al.. (2021). Rhabdomyosarcoma. Pediatric Blood & Cancer. 68(S2). e28254–e28254. 19 indexed citations
5.
Inskip, Peter D., Alice J. Sigurdson, Lene H. S. Veiga, et al.. (2015). Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects. International Journal of Radiation Oncology*Biology*Physics. 94(4). 800–807. 98 indexed citations
6.
Veiga, Lene H. S., Parveen Bhatti, Cécile M. Ronckers, et al.. (2012). Chemotherapy and Thyroid Cancer Risk: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiology Biomarkers & Prevention. 21(1). 92–101. 82 indexed citations
7.
Mascarenhas, Leo, Elizabeth Lyden, Philip P. Breitfeld, et al.. (2010). Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 28(30). 4658–4663. 80 indexed citations
8.
La, Trang H., Suzanne L. Wolden, Zheng Su, et al.. (2010). Local Therapy for Rhabdomyosarcoma of the Hands and Feet: Is Amputation Necessary? A Report From the Children's Oncology Group. International Journal of Radiation Oncology*Biology*Physics. 80(1). 206–212. 13 indexed citations
9.
Green, Daniel M., Toana Kawashima, Marilyn Stovall, et al.. (2009). Fertility of Female Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 27(16). 2677–2685. 365 indexed citations
10.
Inskip, Peter D., Leslie L. Robison, Marilyn Stovall, et al.. (2009). Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 27(24). 3901–3907. 167 indexed citations
11.
Tran, Phuoc T., Pavan Bachireddy, Robert B. West, et al.. (2009). External Beam Radiation Therapy Enhances Local Control in Pigmented Villonodular Synovitis. International Journal of Radiation Oncology*Biology*Physics. 75(1). 183–187. 45 indexed citations
12.
Donaldson, Sarah S., Michael P. Link, Howard J. Weinstein, et al.. (2007). Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease. Journal of Clinical Oncology. 25(3). 332–337. 86 indexed citations
13.
Yock, Torunn I., Mark Krailo, Christopher Fryer, et al.. (2006). Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 24(24). 3838–3843. 100 indexed citations
14.
Mertens, Ann, James G. Gurney, Yutaka Yasui, et al.. (2005). Long‐term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the childhood cancer survivor study. Pediatric Blood & Cancer. 44(7). 643–653. 68 indexed citations
15.
Michalski, Jeff M., Jane L. Meza, John C. Breneman, et al.. (2004). Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. International Journal of Radiation Oncology*Biology*Physics. 59(4). 1027–1038. 69 indexed citations
16.
Raney, R. Beverly, James R. Anderson, Frederic G. Barr, et al.. (2001). Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V. ˜The œAmerican journal of pediatric hematology/oncology. 23(4). 215–220. 273 indexed citations
17.
Breitfeld, Philip P., Elizabeth Lyden, R. Beverly Raney, et al.. (2001). Ifosfamide and Etoposide Are Superior to Vincristine and Melphalan for Pediatric Metastatic Rhabdomyosarcoma When Administered With Irradiation and Combination Chemotherapy: A Report From the Intergroup Rhabdomyosarcoma Study Group. ˜The œAmerican journal of pediatric hematology/oncology. 23(4). 225–233. 56 indexed citations
18.
Shaw, Richard J., et al.. (2000). Case Study: Suprasellar Germinoma Presenting With Psychotic and Obsessive-Compulsive Symptoms. Journal of the American Academy of Child & Adolescent Psychiatry. 39(1). 116–119. 23 indexed citations
19.
Raney, R. Beverly, James R. Anderson, Richard J. Andrassy, et al.. (2000). Soft-Tissue Sarcomas of the Diaphragm: A Report From the Intergroup Rhabdomyosarcoma Study Group From 1972 to 1997. ˜The œAmerican journal of pediatric hematology/oncology. 22(6). 510–514. 14 indexed citations
20.
Benk, V., C Rodary, Sarah S. Donaldson, et al.. (1996). Parameningeal rhabdomyosarcoma: Results of an International Workshop. International Journal of Radiation Oncology*Biology*Physics. 36(3). 533–540. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helmut Gadner Breakdown of academic impact, for papers by Mark Krailo Breakdown of academic impact, for papers by Anna T. Meadows Breakdown of academic impact, for papers by Holcombe E. Grier Breakdown of academic impact, for papers by Andrea Ferrari Breakdown of academic impact, for papers by Larry E. Kun Breakdown of academic impact, for papers by Nancy J. Tarbell Breakdown of academic impact, for papers by Marilyn Stovall Breakdown of academic impact, for papers by James R. Anderson Breakdown of academic impact, for papers by Robert E. Scully
Rankless by CCL
2026